Skip to main content
SpringerLink
Log in

Therapeutic Conservatism: More Costly in the Long Term?

A UK Perspective

  • Leading Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Griffin JP, Griffin TD. The economic implications of therapeutic conservatism. In: Teeling-Smith G, editor. Innovative competition in medicine: a Schumpeterian analysis of the pharmaceutical industry and the NHS. London: Office of Health Economics, 1992

    Google Scholar 

  2. Griffin JP, Griffin TD. The economic implications of therapeutic conservatism. J R Coll Physicians Lond 1993; 27: 121–6

    PubMed  CAS  Google Scholar 

  3. Bundesverband der Pharmazeutischen Industrie (BPI). Pharmaceutical data 1993. Frankfurt: BPI, 1994

  4. Griffin JP, Diggle GE, A survey of products license in the United Kingdom from 1971–1981. Br Join Pharmacol 1981: 12: 453–63

    Article  CAS  Google Scholar 

  5. Barral PE, Twelve years of results in pharmaceutical research throughout the world 1975–1986. Paris: Foundation Rhone-Poulenc Sante, 1987

  6. Rawlins MD, Jefferies DB, Study of United Kingdom product licence applications containing new active substances 1987–89. BMJ 1991; 302: 223–5

    Article  PubMed  CAS  Google Scholar 

  7. Rawlins MD, Mann RD. Monitoring adverse events and reactions In:Mann RD, Rawlins MD, Auty RM, editors. A textbook of pharmaceutical medicine. Carnforth: Parthenon Publishing, 317–22

  8. Walley T, Wilson R, Bligh J. Current prescribing in primary care in the UK: effects or the indicative prescribing scheme and GP fundholding. Pharmacoeconomics 1995; 7 (4); 320–31

    Article  PubMed  CAS  Google Scholar 

  9. The Audit Commission. A prescription for improvement. London: Her Majesty’s Stationery Office, 1994

  10. MIMS Weekly Survey 1994 Jun 23

  11. Laurance J. Drug firms asked not to use foetuses for vaccines. The Times 1994 Nov 2: 5 (col. 1)

  12. Hunt L. New measles vaccine urged. The Independent 1994 Nov 2: 2 (col. 3)

  13. Fletcber AP. Approaching a century and after: morbidity and potentially drug induced disease. Adv Drug React Toxicol Rev 1995: 14: 1–20

    Google Scholar 

  14. Weber JCP, Griffin JP. Prescriptions, adverse reactions and the elderly. Lancet 1986: 1: 1220

    Article  PubMed  CAS  Google Scholar 

  15. Weber JCP, Griffin JP. Adverse reactions and the elderly. Lancet 1986: 2: 291–2

    Article  PubMed  CAS  Google Scholar 

  16. Griffin JP, Chew RB. Trends in usage of prescription medicines by the elderly and very elderly between 1917–1988. London: Association of British Pharmaceutical Industries, 1990

  17. Griffin JP. Is therapeutic conservatism cost effective prescribing? European Federation of Pharmaceutical Industries Associations (EFPIA). General assembly conference–a new socia–economic order in twenty–first century Europe: act or acquiesce?: 1993 May 24-26: Salzburg. Berlin: EFPIA. 1993

    Google Scholar 

  18. Combined report On regular dialysis and transplantation in Europe, XXI: 1990. Nephrol Dial Transplant 1991: 6 (4): 5–29

    Google Scholar 

  19. Mallick NP, Wight J. Quoted in: Conference Report Rationing Health Care in Medicine. J R Coll Physicians Lond 1993; 27: 175–6

    Google Scholar 

  20. Griffin JP. Cheap prescribing–can we afford it? London: Association of British Pharmaceutical Industries, 1994

    Google Scholar 

  21. Griffin JR. Osteoporosis and the risk of fracture. No. 94 in a series of papers on current health problems. London: Office of Health Economics, 1990

    Google Scholar 

  22. Griffin JP, Teeling-Smith G. A veiw of the pharmaceutical industry On cost effective prescribing. Int Pharm J 1992: 6: 58–63

    Google Scholar 

  23. Mugford H, Kingston J, Chalmers I. Reducing the incidence of infection after Caesarian sections: implications of prophylaxis with antibiotics for hospital resources. BMJ 1989; 299: 1003–6

    Article  PubMed  CAS  Google Scholar 

  24. Persson U, Montgomery F, Carlsson A. et al. How far does prophylaxis against infection in total joint replacement offset its cost? BMJ 1988: 296: 99–102

    Article  PubMed  CAS  Google Scholar 

  25. Bell GD, Powell KV, Bolton G. et al. Clinical and pharmacoeconomic evaluation of management strategies for duodenal ulcer disease. Br J Med Econ 1993: 6: 45–58

    Google Scholar 

  26. BLISS (Baby Life Support Systems). Survey of neonatal resources. London: BLISS, 1993

  27. Williams JR, Flowerdew ADS. Uptake of immunisation against hepatitis B among surgeons in Wessex Regional Health Authority. BMJ 1990: 301: 154

    Article  PubMed  CAS  Google Scholar 

  28. Porteous MJ, Le F. Operating practices of and precautions taken by orthopaedic surgeons to avoid infection with HIV and hepatitis B virus during surgery. BMJ 1990; 301: 167–9

    Article  PubMed  CAS  Google Scholar 

  29. Turner RS, Heatley FW. Aspects of ‘safe’ surgery. Injury 1991: 22: 223–4

    Article  PubMed  CAS  Google Scholar 

  30. Occupational infection among anaesthetists [editorial]. Lancet 1990: 336: 1103

  31. Dudley HAF. Blood–borne infections in the work–place. BMJ 1989: 299: 699–700

    Article  PubMed  CAS  Google Scholar 

  32. Kinnersley P. Attitudes of general practitioners towards their vaccination against hepatitis B. BMJ 1990; 300; 238

    Article  PubMed  CAS  Google Scholar 

  33. Department of Health and Social Security. On the State of the public health: the annual report of the Chief Medical Officer of the Department of Health and Social Security for the year 1982. London: Her Majesty’s Stationery Office, 1983

  34. Department of Health and Social Security. Immunisation against infectious diseases. London: Her Majesty’s Stationery Office, 1988: 70–8

  35. Frost B. Women inundate hospital hotline in hepatitis scare. The Times 1993 Feb 2: 2 (col. 2)

    Google Scholar 

  36. Screening extended in hepatitis B scare. The Times 1993 Feb 8: 2 (col. 4)

  37. Pallot P. 770 women call hotline on hepatitis. Daily Telegraph 1993 Feb 2; 6 (col. 1)

  38. Myhill C. Women seek checks in hepatitis scare. The Guardian 1993 Feb 2; 4 (col.1)

  39. Hunt L. Counselling offered after hepatitis alert. The Independent 1993 Feb 2: 2 (col. 6)

  40. Mr John Major, Prime Minister. Hansard 1993 Mar 25 (col. 709). London: Her Majesty’s Stationery Office, 1993

    Google Scholar 

  41. Duce R. Hepatitis doctor jailed for terrible deception. The Times 1994 Sep 30; 5 (col. 1)

  42. Pallot P. Hepatitis B scare after two doctors test positive. Daily Telegraph 1994 Nov 5: 9 (col. 2)

  43. Lahaye D, Strauss P, Baleux C, et al. Cost benefit analysis of hepatitis B vaccination. Lancet 1987; 2: 441–3

    Article  PubMed  CAS  Google Scholar 

  44. Bottomley V. The Financial Times Pharmaceutical Conference 1994 Mar 24: Department of Health Press Release

  45. Laurance J. Doctors accuse trust chief who told them to put patients last. The Times 1994 Nov 14: 6 (col. 1)

  46. Willetts D. Member of Parliament. Hansard 1993 Feb 17 (col. 28). London: her Majesty’s Stationery Office, 1993

    Google Scholar 

  47. Advisory Council on Science and Technology. A report on medical research and health. London: Her Majesty’s Stationery Office. 1993: 28

Download references

Author information

Authors and Affiliations

  1. Quartermans, Digswell Lane, Digswell, AL7 1SP, Welwyn Garden City, Hertfordshire, England

    John P. Griffin (Independent Medical Consultant)

Authors
  1. John P. Griffin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Griffin, J.P. Therapeutic Conservatism: More Costly in the Long Term?. Pharmacoeconomics 7, 378–387 (1995). https://doi.org/10.2165/00019053-199507050-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199507050-00002

Keywords

Search

Navigation